Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Effect of large targeted deletions on the mitotic stability of an extra chromosome mediating drug resistance in Leishmania.

Dubessay P, Ravel C, Bastien P, Lignon MF, Ullman B, Pagès M, Blaineau C.

Nucleic Acids Res. 2001 Aug 1;29(15):3231-40.

2.

Molecular cloning and functional expression of a novel human gene encoding two 41-43 kDa skeletal muscle internal membrane proteins.

Bouju S, Lignon MF, Piétu G, Le Cunff M, Léger JJ, Auffray C, Dechesne CA.

Biochem J. 1998 Nov 1;335 ( Pt 3):549-56.

3.

CholecystokininB receptor from human Jurkat lymphoblastic T cells is involved in activator protein-1-responsive gene activation.

Oiry C, Gagne D, Cottin E, Bernad N, Galleyrand JC, Bergé G, Lignon MF, Eldin P, Le Cunff M, Léger J, Clerc P, Fourmy D, Martinez J.

Mol Pharmacol. 1997 Aug;52(2):292-9.

PMID:
9271352
4.

Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.

Lallement JC, Oiry C, Lima-Leite AC, Lignon MF, Fulcrand P, Galleyrand JC, Martinez J.

Eur J Pharmacol. 1995 Jul 18;290(2):61-7.

PMID:
8575534
5.

Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation.

Kolodziej SA, Nikiforovich GV, Skeean R, Lignon MF, Martinez J, Marshall GR.

J Med Chem. 1995 Jan 6;38(1):137-49.

PMID:
7837225
6.

Synthesis and characterization of a new labeled gastrin ligand, 125-I-BH-[Leu15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells.

Galleyrand JC, Lima-Leite AC, Lallement JC, Lignon MF, Bernad N, Fulcrand P, Martinez J.

Int J Pept Protein Res. 1994 Oct;44(4):348-56.

PMID:
7875937
7.

Cholecystokinin receptors in cells of the immune system.

Lignon MF, Bernad N, Martinez J.

Ann N Y Acad Sci. 1994 Mar 23;713:334-7. No abstract available.

PMID:
8185180
8.

Biological evaluation of JMV180 cholecystokinin analogs.

Amblard M, Lignon MF, Bernad N, Noel-Artis AM, Hauad L, Laur J, Rodriguez M, Galas MC, Fourmy D, Martinez J.

Ann N Y Acad Sci. 1994 Mar 23;713:79-87. Review. No abstract available.

PMID:
7514377
9.

Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.

Amblard M, Rodriguez M, Lignon MF, Galas MC, Bernad N, Artis-Noël AM, Hauad L, Laur J, Califano JC, Aumelas A, et al.

J Med Chem. 1993 Oct 1;36(20):3021-8.

PMID:
7692048
10.

Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.

Lignon MF, Bernad N, Martinez J.

Eur J Pharmacol. 1993 May 15;245(3):241-6.

PMID:
8335062
11.

Pharmacological characterization of new cholecystokinin analogues.

Maletínská L, Lignon MF, Galas MC, Bernad N, Pírková J, Hlavácek J, Slaninová J, Martinez J.

Eur J Pharmacol. 1992 Nov 10;222(2-3):233-40.

PMID:
1280592
12.

Large and prolonged in vivo response of pancreatic secretion to phenylethylamide and phenylethylester derivatives of Boc-[Nle28-Nle31]CCK(26-33) in the rat.

Nagain C, Lignon MF, Galas MC, Rodriguez M, Martinez J, Rozé C.

Peptides. 1992 Nov-Dec;13(6):1127-32.

PMID:
1494494
13.

Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region.

Rolland M, Rodriguez M, Lignon MF, Galas MC, Laur J, Aumelas A, Martinez J.

Int J Pept Protein Res. 1991 Aug;38(2):181-92.

PMID:
1723720
14.
15.

Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists.

Nagain C, Galas MC, Lignon MF, Rodriguez M, Martinez J, Rozé C.

Pancreas. 1991 May;6(3):275-81.

PMID:
1713671
16.

[Structure-activity relationship of cystokinins: analogs exhibiting selective activity].

Martinez J, Rodriguez M, Lignon MF, Galas MC, Amblard M, Rolland M, Mendre C, Fulcrand P, Laur J, Bernad N.

J Pharm Belg. 1991 Jan-Feb;46(1):9-16. Review. French.

PMID:
2051303
17.

Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.

Mendre C, Rodriguez M, Lignon MF, Galas MC, Gueudet C, Worms P, Martinez J.

Eur J Pharmacol. 1990 Sep 21;186(2-3):213-22.

PMID:
1705230
18.

Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.

Rodriguez M, Lignon MF, Galas MC, Amblard M, Martinez J.

Mol Pharmacol. 1990 Sep;38(3):333-41.

PMID:
1698251
19.

Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.

Rodriguez M, Amblard M, Galas MC, Lignon MF, Aumelas A, Martinez J.

Int J Pept Protein Res. 1990 May;35(5):441-51.

PMID:
2376470
21.

Synthesis and biological activities of some cholecystokinin analogues substituted in position 29 by a beta-alanine.

Rodriguez M, Rolland M, Lignon MF, Galas MC, Laur J, Aumelas A, Martinez J.

Int J Pept Protein Res. 1989 Nov;34(5):394-404.

PMID:
2482263
22.

Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.

Rodriguez M, Galas MC, Lignon MF, Mendre C, Laur J, Aumelas A, Martinez J.

J Med Chem. 1989 Oct;32(10):2331-9.

PMID:
2477546
23.

2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.

Fulcrand P, Rodriguez M, Galas MC, Lignon MF, Laur J, Aumelas A, Martinez J.

Int J Pept Protein Res. 1988 Nov;32(5):384-95.

PMID:
2463231
24.

A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.

Mendre C, Rodriquez M, Gueudet C, Lignon MF, Galas MC, Laur J, Worms P, Martinez J.

J Biol Chem. 1988 Aug 5;263(22):10641-5.

25.

Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.

Galas MC, Lignon MF, Rodriguez M, Mendre C, Fulcrand P, Laur J, Martinez J.

Am J Physiol. 1988 Feb;254(2 Pt 1):G176-82.

PMID:
2450468
26.

Degradation of a tetragastrin analogue by a membrane fraction from rat gastric mucosa.

Dubreuil P, Lignon MF, Magous R, Rodriguez M, Bali JP, Martinez J.

Drug Des Deliv. 1987 Sep;2(1):49-54.

PMID:
3509344
27.

Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.

Rodriguez M, Lignon MF, Galas MC, Fulcrand P, Mendre C, Aumelas A, Laur J, Martinez J.

J Med Chem. 1987 Aug;30(8):1366-73.

PMID:
2441054
28.

A synthetic peptide derivative that is a cholecystokinin receptor antagonist.

Lignon MF, Galas MC, Rodriguez M, Laur J, Aumelas A, Martinez J.

J Biol Chem. 1987 May 25;262(15):7226-31.

29.

Pharmacological profile of a new peptidic gastrin antagonist.

Lavezzo A, Bali JP, Magous R, Lignon MF, Nisato D, Laur J, Castro B, Martinez J.

Regul Pept. 1986 Sep;15(2):111-9.

PMID:
3786833
30.

Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone.

Martinez J, Bali JP, Rodriguez M, Castro B, Magous R, Laur J, Lignon MF.

J Med Chem. 1985 Dec;28(12):1874-9.

PMID:
2999406
31.

Abilities of some tryptophan and phenylalanine derivatives to inhibit gastric acid secretion.

Magous R, Martinez J, Lignon MF, Nisato D, Castro B, Bali JP.

Biochim Biophys Acta. 1985 May 30;845(2):158-62.

PMID:
2986716
32.

Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity.

Martinez J, Bali JP, Magous R, Laur J, Lignon MF, Briet C, Nisato D, Castro B.

J Med Chem. 1985 Mar;28(3):273-8.

PMID:
3973899
33.

Synthesis and biological activity of new peptide segments of gastrin exhibiting gastrin antagonist property.

Martinez J, Magous R, Lignon MF, Laur J, Castro B, Bali JP.

J Med Chem. 1984 Dec;27(12):1597-601.

PMID:
6094810
34.

The role of the Asp-32 residue of cholecystokinin in gastric acid secretion and gastrin receptor recognition.

Magous R, Martinez J, Lignon MF, Bali JP.

Regul Pept. 1983 Mar;5(4):327-32.

PMID:
6304819
35.

N alpha-Glycosylgastrin-related peptides. Synthesis, characterization and biological activity.

Previero A, Mourier G, Bali JP, Lignon MF, Moroder L.

Hoppe Seylers Z Physiol Chem. 1982 Aug;363(8):813-8. No abstract available.

PMID:
7118076
36.

Supplemental Content

Loading ...
Support Center